Fleur%20de%20Lisa%20Large%20CrossAffinity House Calls, PLLC

 Lisa Tabor, APRN, ACNP-BC, CEN

Adult/Acute Nurse Practitioner

2851 Johnston St.  ¤  Suite 535  ¤  Lafayette, LA  70503

337.988.8511  ¤  Fax:  858.373.2485  ¤  lisa@affinityhousecalls.com

www.affinityhousecalls.com

 

 

“Bringing the Healthcare Visit to You”

 

 

FOBT test kitHemoccult® Fecal Occult Blood Test

 

For thirty years, the Hemoccult® fecal occult blood test (FOBT) has been aiding physicians in detecting hidden blood in stool specimens as an early indication of colorectal cancer. More than 300 studies using Hemoccult® products – many of which were conducted over long periods of time with large numbers of participants- have been published in leading medical journals around the world. As a result of these studies, the American Cancer Society and other healthcare and medical agencies now recommend annual FOBT screening for people age 50 and older.

 

Art:A comparison of the portions of the colon examined through sigmoidoscopy and colonoscopy.http://cms.uspharmacist.com/Images/Articles/Diagnostic-T1.jpg

         

 

 

 

 

 

 

 

 

 

People should talk to their practitioner about starting colorectal cancer screening earlier and/or being screened more often if they have any of the following colorectal cancer risk factors:

·         A personal history of colorectal cancer or adenomatous polyps

·         A personal history of chronic inflammatory bowel disease (Chron’s Disease, Irritable Bowel Syndrome or Ulcerative Colitis)

·         A strong family history of colorectal cancer or polyps (cancer or polyps in a first-degree relative [parent, sibling or child] younger than 60 or in 2 or more first-degree relatives of any age)

·         A known family history of hereditary colorectal cancer syndromes such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colon cancer (HNPCC)

 

 

 

 

 

 

http://www.hemoccultfobt.com/

American Cancer Society Guidelines for the Early Detection of Cancer - http://www.cancer.org/docroot/ped/content/ped_2_3x_acs_cancer_detection_guidelines_36.asp